|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.95 AUD | +1.92% |
|
+17.63% | +51.34% |
| 08-07 | ASX Biggest Gainers | MT |
| 07-24 | Telix Says Thyroid Cancer Therapy Candidate Shows Encouraging Disease Control, Acceptable Safety Profile in Real-World Data Review | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 17.38 | 17.38 | 16.88 |
| Spread/Res. | -2.47% | -2.47% | +0.41% |
| Spread/Supp. | +20.47% | +38.93% | +41.01% |
| Support | 14.07 | 12.2 | 12.02 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TLX Stock
- Charts Telix Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
